Antineoplastic Drug Administration Course

The CDHB utilises the eviQ ADAC programme to credential people to administer antineoplastic drugs. eviQ is a web based cancer information service that is run by the Cancer Institute of New South Wales. Find out more about eviQ

ADAC Credentialing Programme Overview

ADAC consists of the following seven e-learning modules, each with an associated quiz.

  1. Handling antineoplastic drugs and related waste safely
  2. Understanding how antineoplastic drugs work
  3. Reviewing protocols and prescriptions
  4. Educating the patient and carer
  5. Assessing patients
  6. Administering oral antineoplastic drugs
  7. Administering antineoplastic drugs (all routes)

There are 3 competency assessments which are undertaken after successful completion of

  1. Module 1
  2. Modules 2-6
  3. Module 7

You cannot complete Modules 2-6 until Module 1 has been completed. This includes the quiz and the competency assessment. Modules 2-6 can be completed in any order. You cannot complete module 7 until all parts of modules 1-6 (quizzes and competency assessment) have been completed. Successful completion of module 7 includes passing the quiz, attending the workshop and meeting competency assessment. Please review the ADAC Course Overview

These modules are completed alongside supervised clinical practice where you will be expected to complete the ADAC Clinical Log after each administration event.

All trainees will participate in a Clinical Skills Workshop (Schedule) once all e-learning modules have been successfully completed. This one day workshop is aimed to integrate theory and practice. You will be able to book yourself (via health learn) into the workshop once all modules have been completed. It is expected that you will attend this workshop 4-6 weeks into the ADAC credentialing programme.

The benefit of completing the eviQ ADAC credentialing programme is that you will be able to transfer this competency to any health care setting within Australasia that recognises this programme.

Further ADAC Course Information and the ADAC Learning Outcomes and ADAC Learning Contract are available


There are some clinical practice differences between the Adult ADAC credentialing programme and the clinical practice outlined in the CDHB Cytotoxic and Biotherapies Policy that you need to be aware of when completing the course. 

  1. The prescriptions/protocols that are referred to during the ADAC e-learning modules may differ to those that are used at the CDHB.
  2. ADAC highlights a 48 hour to 10 day 'cytotoxic period' from the last chemotherapy given. However, within the CDHB, the cytotoxic period can be from 48 hours to 7 days.
  3. ADAC refers to the use of full personal protective equipment (PPE) when administering antineoplastic drugs. However, the CDHB recommends the use of long sleeve impermeable gown and gloves; mask and goggles are optional.

ADAC do state to follow local area practice. However, in order to successfully answer the e-learning quizzes successfully, you need to use the ADAC guidelines.


When can I start the ADAC credentialing programme?

This will depend on where you work within the haematology/oncology service. All RN's are expected to complete Module 1 of the ADAC credentialing programme within 4 weeks of commencing employment within the haematology/oncology service. If you are working within the inpatient services, you are likely to start Modules 2-7 of the ADAC credentialing programme anywhere from six to eighteen months after starting in that area. If you are working in the outpatient services, you are likely to start within the first 4 weeks of employment.

Once it is agreed that you can start the ADAC credentialing programme, a plan will be developed with you using the learning contract.

How do I access the ADAC course?

The ADULT ADAC credentialing programme is accessible via health learn.

As the CDHB utilises many eviQ courses (including a paediatric ADAC), make sure you have enrolled in the correct course. You will have 3 parts to complete. They are the Adult ADAC Module 1; the Adult ADAC Modules 2-6 & Adult ADAC Module 7. 


How do I learn to administer antineoplastic drugs?

As soon as it is agreed, you will begin to administer antineoplastic drugs under direct supervision in your clinical area.  This will initially be with the CNS and/or NE that works in your area. You will be mentored and coached to develop logical processes to enable you to administer antineoplastic drugs to the expected standard. As your experience and confidence grows and you demonstrate sound clinical practice, you will be able to administer antineoplastic drugs more autonomously with the goal being independent practice on course completion.


When do I become a second checker?

This is a decision that is made between you and the person overseeing your training. There isn't a time frame associated with this. You will become a second checker when you have successfully completed Module 3, Reviewing protocols and prescriptions and have demonstrated that you understand the role and responsibilities associated with medication checking antineoplastic medications and that you carry out those requirements consistently. This also includes confidence in reading/reviewing/ verifying the prescription, consent and any other pre-treatment tests and investigations that are required.


Why are there competency assessments?

Competence assessment provides an opportunity to formally assess practice. This includes the integration of knowledge and skills to ensure that the expected standard for antineoplastic drug administration is being met.

At the end of each competency assessment, you will be able to print off a certificate of completion for your portfolio.


How long will it take to complete the credentialing programme?

The timeline for completion will vary depending on the area you work in. In those areas where antineoplastic drugs are administered frequently, it is expected that credentialing will be completed by 2 months. In areas where antineoplastic drugs are given less frequently, credentialing may take 3 months.


What resources are available to complete the credentialing programme?

There are many resources available to support your learning. These include:


What are my responsibilities during training?

As an adult learner, it is expected that you will commit to the plan that has been developed for you. To meet the timeframe, you will need to complete some of this work in your own time. This has been recognised with the 10 hours of PD that is given. To enhance your learning experience, your roster may need to be adjusted. If this is the case, it will be done by mutual agreement.

You are responsible for your own learning. If you are unable to meet the agreed timeframe/plan please meet with the CNS/NE in your area sooner rather than later to discuss options.


When do I become credentialed to administer antineoplastic drugs?

You will be credentialed to administer oral antineoplastic drugs when you have successfully completed modules 1-6, including the quizzes and the associated competency assessments.

Credentialing to administer antineoplastic drugs by all other routes will be obtained once you have successfully completed module 7; the associated quiz; attended the workshop and achieved competency.

How much professional development (PD) is given on completion of this course?

eviQ allocate a total of 22 hours broken down to the following

  • Successful completion of Module 1 is 2 hours
  • Successful completion of Modules 2-6 is 10 hours
  • Successful completion of Module 7 is 10 hours which includes the workshop

A further 10 hours of PD is given in recognition of all the reading/researching/reflection that is required to complete the course.

Therefore you will be given a total of 32 hours of PD; 22 hours will be recognised in Health Learn and 10 hours will be entered on the CDHB Staff Competency and Training database on course completion under ADAC PD.

Page last reviewed: 22 January 2018
Contact Us
Image of a Phone By Phone
Image of an Email sign By Email

For a full list of the convenient ways that you can contact us, refer to the Contact Us page